Ignite Creation Date:
2025-12-24 @ 5:39 PM
Ignite Modification Date:
2025-12-25 @ 3:09 PM
Study NCT ID:
NCT03789968
Status:
COMPLETED
Last Update Posted:
2020-10-08
First Post:
2018-12-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
The Incidence and Severity of Drug Interactions Before and After Switching Antiretroviral Therapy to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment Experienced Patients
Sponsor:
Thomas Jefferson University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-09-01
Start Date Type:
ACTUAL
Primary Completion Date:
2020-09-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-10-05
Completion Date Type:
ACTUAL
First Submit Date:
2018-12-26
First Submit QC Date:
None
Study First Post Date:
2018-12-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-10-05
Last Update Post Date:
2020-10-08
Last Update Post Date Type:
ACTUAL